495 related articles for article (PubMed ID: 28432571)
21. An arduous journey from human pluripotent stem cells to functional pancreatic β cells.
Loo LSW; Lau HH; Jasmen JB; Lim CS; Teo AKK
Diabetes Obes Metab; 2018 Jan; 20(1):3-13. PubMed ID: 28474496
[TBL] [Abstract][Full Text] [Related]
22. Mesenchymal stem cell-based therapy for the treatment of type 1 diabetes mellitus.
Mabed M; Shahin M
Curr Stem Cell Res Ther; 2012 May; 7(3):179-90. PubMed ID: 22023626
[TBL] [Abstract][Full Text] [Related]
23. Generating pancreatic beta-like cells from human pluripotent stem cells.
Lim LY; Ching C; Kong D; Chan SY; Teo AKK
Methods Cell Biol; 2022; 170():127-146. PubMed ID: 35811096
[TBL] [Abstract][Full Text] [Related]
24. Importance of multiple endocrine cell types in islet organoids for type 1 diabetes treatment.
Heaton ES; Jin S
Transl Res; 2022 Dec; 250():68-83. PubMed ID: 35772687
[TBL] [Abstract][Full Text] [Related]
25. The state of the art of islet transplantation and cell therapy in type 1 diabetes.
Pellegrini S; Cantarelli E; Sordi V; Nano R; Piemonti L
Acta Diabetol; 2016 Oct; 53(5):683-91. PubMed ID: 26923700
[TBL] [Abstract][Full Text] [Related]
26. Generation of Pancreatic β-cells From iPSCs and their Potential for Type 1 Diabetes Mellitus Replacement Therapy and Modelling.
Csobonyeiova M; Polak S; Danisovic L
Exp Clin Endocrinol Diabetes; 2020 May; 128(5):339-346. PubMed ID: 30114722
[TBL] [Abstract][Full Text] [Related]
27. Challenges with Cell-based Therapies for Type 1 Diabetes Mellitus.
Siwakoti P; Rennie C; Huang Y; Li JJ; Tuch BE; McClements L; Xu X
Stem Cell Rev Rep; 2023 Apr; 19(3):601-624. PubMed ID: 36434300
[TBL] [Abstract][Full Text] [Related]
28. Insulin-secreting cells derived from stem cells: clinical perspectives, hypes and hopes.
Roche E; Reig JA; Campos A; Paredes B; Isaac JR; Lim S; Calne RY; Soria B
Transpl Immunol; 2005 Dec; 15(2):113-29. PubMed ID: 16412956
[TBL] [Abstract][Full Text] [Related]
29. Differentiation of human pluripotent stem cells into β-cells: Potential and challenges.
Quiskamp N; Bruin JE; Kieffer TJ
Best Pract Res Clin Endocrinol Metab; 2015 Dec; 29(6):833-47. PubMed ID: 26696513
[TBL] [Abstract][Full Text] [Related]
30. Stem cell therapy to cure type 1 diabetes: from hype to hope.
Chhabra P; Brayman KL
Stem Cells Transl Med; 2013 May; 2(5):328-36. PubMed ID: 23572052
[TBL] [Abstract][Full Text] [Related]
31. Stem cells differentiation into insulin-producing cells (IPCs): recent advances and current challenges.
Silva IBB; Kimura CH; Colantoni VP; Sogayar MC
Stem Cell Res Ther; 2022 Jul; 13(1):309. PubMed ID: 35840987
[TBL] [Abstract][Full Text] [Related]
32. Restoring insulin production for type 1 diabetes.
Tudurí E; Bruin JE; Kieffer TJ
J Diabetes; 2012 Dec; 4(4):319-31. PubMed ID: 22429761
[TBL] [Abstract][Full Text] [Related]
33. MicroRNAs: Novel Players in the Dialogue between Pancreatic Islets and Immune System in Autoimmune Diabetes.
Ventriglia G; Nigi L; Sebastiani G; Dotta F
Biomed Res Int; 2015; 2015():749734. PubMed ID: 26339637
[TBL] [Abstract][Full Text] [Related]
34. Real-time imaging of the pancreas during development of diabetes.
Martinic MM; von Herrath MG
Immunol Rev; 2008 Feb; 221():200-13. PubMed ID: 18275484
[TBL] [Abstract][Full Text] [Related]
35. From pluripotent stem cells to bioengineered islets: A challenging journey to diabetes treatment.
Carvalho AM; Nunes R; Sarmento B
Eur J Pharm Sci; 2022 May; 172():106148. PubMed ID: 35189271
[TBL] [Abstract][Full Text] [Related]
36. Mesenchymal stem cells in the treatment of type 1 diabetes mellitus.
Katuchova J; Harvanova D; Spakova T; Kalanin R; Farkas D; Durny P; Rosocha J; Radonak J; Petrovic D; Siniscalco D; Qi M; Novak M; Kruzliak P
Endocr Pathol; 2015 May; 26(2):95-103. PubMed ID: 25762503
[TBL] [Abstract][Full Text] [Related]
37. Stem cell-based treatments for Type 1 diabetes mellitus: bone marrow, embryonic, hepatic, pancreatic and induced pluripotent stem cells.
Godfrey KJ; Mathew B; Bulman JC; Shah O; Clement S; Gallicano GI
Diabet Med; 2012 Jan; 29(1):14-23. PubMed ID: 21883442
[TBL] [Abstract][Full Text] [Related]
38. Concise Review: Cell-Based Therapies and Other Non-Traditional Approaches for Type 1 Diabetes.
Creusot RJ; Battaglia M; Roncarolo MG; Fathman CG
Stem Cells; 2016 Apr; 34(4):809-19. PubMed ID: 26840009
[TBL] [Abstract][Full Text] [Related]
39. Therapies for Type 1 Diabetes: Current Scenario and Future Perspectives.
Pathak V; Pathak NM; O'Neill CL; Guduric-Fuchs J; Medina RJ
Clin Med Insights Endocrinol Diabetes; 2019; 12():1179551419844521. PubMed ID: 31105434
[TBL] [Abstract][Full Text] [Related]
40. Increased Hormone-Negative Endocrine Cells in the Pancreas in Type 1 Diabetes.
Md Moin AS; Dhawan S; Shieh C; Butler PC; Cory M; Butler AE
J Clin Endocrinol Metab; 2016 Sep; 101(9):3487-96. PubMed ID: 27300574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
